TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1.

导出 OA

翻译打印收藏纠错

作者： Chao,Gu ^[1] ; Yiwen,Xia ^[2] ; Chen,Lu ^[2] ; Shengkui,Qiu ^[3] ; Jihuan,Wang ^[4] ; Lu,Zhang ^[2] ; Jialun,Lv ^[2] ; Tianlu,Jiang ^[2] ; Lang,Fang ^[2] ; Penghui,Xu ^[2] ; Zetian,Chen ^[2] ; Ying,Li ^[2] ; Li,Xie ^[2] ; Zekuan,Xu ^[5] ; Bowen,Li ^[2]

作者单位： Department of General Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215000, Jiangsu Province, China. ^[1] Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu Province, China. ^[2] Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu Province, China. ^[3] Department of General Surgery, The Second Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, China. ^[4] Department of General Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu Province, China. ^[5] Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 211166, Jiangsu Province, China. ^[6]

关键词 Gastric cancer glycolysis m6A tumor-associated macrophages ubiquitination